Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 8/20 | 0.47 |
| ▸ | ACLY | P53396 | 2/20 | 0.39 |
| ▸ | ACACA | Q13085 | 2/20 | 0.39 |
| ▸ | HMGCR | P04035 | 2/20 | 0.39 |
| ▸ | CDC25A | P30304 | 4/20 | 0.36 |
| ▸ | CDC25B | P30305 | 4/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.34 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.34 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.34 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.34 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6341662 | 0.92 | HSD11B1 (0.45) | EBPACLYACACAHMGCRHSD11B1 | |
| SCHEMBL377472 | 0.88 | ACLY (0.38) | EBPACLYACACAHSD11B1PTPN11 | |
| Niacin SCHEMBL6684757 | 0.86 | EBP (0.39) | EBPACLYACACAHMGCRCDC25A | |
| SCHEMBL8026697 | 0.85 | ACLY (0.39) | EBPACLYACACAHSD11B1PTPN11 | |
| SCHEMBL464758 | 0.85 | HSD11B1 (0.49) | EBPACLYACACAHSD11B1PTPN11 | |
| SCHEMBL10635071 | 0.85 | HSD11B1 (0.40) | EBPACLYACACAHMGCRHSD11B1 | |
| SCHEMBL2257958 | 0.82 | EBP (0.45) | EBPACLYACACAHMGCRCDC25A | |
| SCHEMBL22099803 | 0.82 | EBP (0.47) | EBPACLYACACAHMGCRCDC25A | |
| Ferulate SCHEMBL2563897 | 0.82 | MEN1 (0.42) | EBPACLYACACAHSD11B1 | |
| SCHEMBL10349517 | 0.81 | EBP (0.39) | EBPACLYACACAHMGCRCDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3410 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734960-A1 | STEROL ANALOGS IN LIPID NANOPARTICLE FORMULATIONS | Sanofi Pasteur Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| WO-2026088119-A1 | LIPIDATED TLR7/8 MODULATORS AS ADJUVANTS AND USES THEREOF | PFIZER INC. (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4731606-A1 | IONIZABLE THIOLIPIDS AND USES THEREOF | BioNTech SE (DE) | 2026-04-29 | — | — | EP | claimed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | claimed |
| US-20260020568-A1 | FUNGAL DISEASES REDUCTION AND YIELD IMPROVEMENT METHODS AND COMPOSITION THEREOF | ELICIT PLANT (FR) | 2026-01-22 | — | — | US | claimed |
| US-20260020564-A1 | FUNGAL DISEASES REDUCTION AND YIELD IMPROVEMENT METHODS AND COMPOSITION THEREOF | ELICIT PLANT (FR) | 2026-01-22 | — | — | US | claimed |
| US-20250375534-A1 | COMPLEXES FOR DELIVERY OF NUCLEIC ACIDS | BioNTech SE (DE) | 2025-12-11 | — | — | US | claimed |
| WO-2025242792-A1 | AQUEOUS MINERAL FIBRE BINDER COMPOSITION BASED ON ONE OR MORE PROTEINS, A METHOD FOR MAKING MINERAL FIBRE PRODUCTS AND USE THEREOF | ROCKWOOL A/S (DK) | 2025-11-27 | — | — | WO | claimed |
| WO-2025235978-A1 | SYSTEMS AND METHODS FOR STABLE CELLULAR MEDIA | MEMBRANE PROTECTIVE TECHNOLOGIES, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250338841-A1 | Dry Powdered Compositions and Methods and Uses Thereof | NEOZYME INTERNATIONAL, INC. (US) | 2025-11-06 | — | — | US | claimed |
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| US-4745136-A | Polyurethanes prepared from dispersions or solutions of cholesterol or cholestanol-containing polymers in a polyol | THE DOW CHEMICAL COMPANY (US) | 1988-05-17 | — | — | US | claimed |
| EP-0216927-A1 | CYCLOARTENYL FERRULATE-CYCLODEXTRIN COMPLEX | ZERIA SHINYAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-04-08 | — | — | EP | claimed |
| CN-85109752-A | Preparation triterpenoid organic acid ester and the method that contains the hypolipidemic agents of this compounds | — | 1986-12-17 | — | — | CN | claimed |
| US-4612187-A | Oryzanol-containing soft capsule | NISSHIN CHEMICALS CO., LTD. (JP) | 1986-09-16 | — | — | US | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
| EP-0007474-B1 | STEROLINHEMIESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Roecar Holdings (Netherlands Antilles) N.V. (AN) | 1985-01-23 | — | — | EP | claimed |
| US-4393044-A | HIGH RESISTANCE TO HYDROLYSIS | THE NISSHIN OIL MILLS LIMITED (JP) | 1983-07-12 | — | — | US | claimed |
| US-4254111-A | ANTIINFLAMMATORY STERYL GLYCOSIDE HEMIESTERS | ROECAR HOLDINGS (NETHERLANDS ANTILLES) NV (NL) | 1981-03-03 | — | — | US | claimed |
| EP-0007474-A1 | Sterolinhemiesters, process for their preparation and pharmaceutical compositions containing them | Roecar Holdings (Netherlands Antilles) N.V. (AN) | 1980-02-06 | — | — | EP | claimed |